EW logo

Edwards Lifesciences (EW)

Profile

Full Name

Edwards Lifesciences Corporation

Ticker Symbol

EW

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

March 27, 2000

Indexes

S&P 500

Website

http://www.edwards.com

Employees

15800

Key Details

Price

$74.80(+1.52%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$5.44B(+8.57% YoY)

Annual EPS

$6.97(+203.04% YoY)

PE ratio

10.69

Next earnings date

Jul 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $74.80
    EW price is $74.80

    30-Day Relative Volume

    0.63
    EW 30-day relative volume is 0.63

    Price Performance

    Price Today change

    +1.52%
    EW price is up +1.52% today

    Price YTD change

    +1.04%
    EW price is up +1.04% since January 1st

    Price 1-year change

    -13.75%
    EW price is down -13.75% year-on-year

    Price 3-year change

    -19.95%
    EW price is down -19.95% over the past 3 years

    Price Range

    Price All-time high

    $131.73
    EW price is currently -43.22% below its historical high of $131.73

    Price 3-year low

    $58.93
    EW price is currently +26.93% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $43.88B
    EW market capitalization is $43.88 billion

    Market cap 3-year change

    -24.47%
    EW market capitalization is down -24.47% over the past 3 years

    Market cap All-time high

    $81.59B
    EW market capitalization is currently -46.22% below its historical high of $81.59 billion

    Market cap sector rank

    97.23%
    EW market capitalization is higher than 97.23% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -2.66%
    EW shares outstanding is down -2.66% year-on-year

    Shares Outstanding 3-Year Change

    -5.65%
    EW shares outstanding is down -5.65% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.58
    EW beta is 0.58

    200-day SMA

    $69.99
    EW price is currently +6.87% above its 200-day simple moving average

    50-day SMA

    $71.66
    EW price is currently +4.38% above its 50-day simple moving average

    RSI

    56.58
    EW 14-day relative strength index is 56.58

    Volume

    0.63
    EW 30-day relative volume is 0.63

    ATR

    $1.82
    EW average true range is $1.82

    10-day Historical Volatility

    14.33%
    EW 10-day historical volatility is 14.33%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $5.44B
    EW annual revenue is $5.44 billion

    Revenue Analysts estimate

    $5.89B
    EW annual revenue is currently -7.64% lower than the consensus analysts' forecast

    Revenue 1-year change

    +8.57%
    EW annual revenue is up +8.57% year-on-year

    Revenue Sector rank

    92.2%
    EW annual revenue is higher than 92.2% of companies in Healthcare sector

    EPS

    EPS

    $6.97
    EW annual earnings per share is $6.97

    EPS Analysts estimate

    $2.47
    EW annual earnings per share is currently +182.56% higher than the consensus analysts' forecast

    EPS 1-year change

    +203.04%
    EW annual earnings per share is up +203.04% year-on-year

    EPS Sector rank

    97.12%
    EW annual earnings per share is higher than 97.12% of companies in Healthcare sector

    Profit

    Gross profit

    $4.32B
    EW annual gross profit is $4.32 billion

    Gross margin

    79.46%
    EW annual gross profit margin is 79.46%

    Operating profit

    $1.48B
    EW annual operating income is $1.48 billion

    Operating margin

    27.21%
    EW annual operating profit margin is 27.21%

    Net income

    $4.17B
    EW annual net profit is $4.17 billion

    Net margin

    76.75%
    EW annual net profit margin is 76.75%

    Expenses

    Total expenses

    $3.96B
    EW annual total expenses is $3.96 billion

    Operating expenses

    $2.84B
    EW annual total operating expenses is $2.84 billion

    Cost of goods sold

    $1.12B
    EW annual cost of goods sold is $1.12 billion

    Selling, general & administrative expenses

    $1.79B
    EW annual SGA is $1.79 billion

    Depreciation and amortization

    $155.20M
    EW annual depreciation & amortization is $155.20 million

    Interest expense

    $19.80M
    EW annual interest expense is $19.80 million

    Income tax

    $152.10M
    EW annual income tax is $152.10 million

    EBIT & EBITDA

    EBIT

    $1.48B
    EW annual earnings before interest & taxes is $1.48 billion

    EBITDA

    $1.48B
    EW annual EBITDA is $1.48 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $13.06B
    EW annual total assets is $13.06 billion

    Non current assets

    $6.77B
    EW annual long term assets is $6.77 billion

    Current assets

    $6.29B
    EW annual total current assets is $6.29 billion

    Cash and cash equivalents

    $3.05B
    EW annual cash & cash equivalents is $3.05 billion

    Accounts receivable

    $609.10M
    EW annual accounts receivable is $609.10 million

    Inventory

    $1.09B
    EW annual inventory is $1.09 billion

    Liabilities

    Total liabilities

    $2.99B
    EW annual total liabilities is $2.99 billion

    Long term liabilities

    $1.49B
    EW annual total long term liabilities is $1.49 billion

    Current liabilities

    $1.51B
    EW annual total current liabilities is $1.51 billion

    Accounts payable

    $197.40M
    EW annual accounts payable is $197.40 million

    Debt

    Total debt

    $700.00M
    EW annual total debt is $700.00 million

    Total debt 1-year change

    +2.17%
    EW annual total debt is up +2.17% year-on-year

    Long term debt

    $676.60M
    EW annual long term debt is $676.60 million

    Short term debt

    $23.40M
    EW annual short term debt is $23.40 million

    Equity & Capital

    Shareholders equity

    $10.00B
    EW annual stockholders equity is $10.00 billion

    Book value

    $10.00B
    EW annual book value is $10.00 billion

    Retained earnings

    $13.17B
    EW annual retained earnings is $13.17 billion

    Working capital

    $4.78B
    EW annual working capital is $4.78 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $542.30M
    EW annual cash flow from operations is $542.30 million

    Cash from operations 1-year change

    -39.46%
    EW annual cash flow from operations is down -39.46% year-on-year

    Cash from investing

    $2.31B
    EW annual cash flow from investing activities is $2.31 billion

    Cash from investing 1-year change

    +1230.78%
    EW annual cash flow from investing activities is up +1230.78% year-on-year

    Cash from financing

    -$983.00M
    EW annual cash flow from financing activities is -$983.00 million

    Cash from financing 1-year change

    -38.26%
    EW annual cash flow from financing activities is down -38.26% year-on-year

    CAPEX

    CAPEX

    $282.40M
    EW annual capital expenditures is $282.40 million

    CAPEX 1-year change

    +6.05%
    EW annual capital expenditures is up +6.05% year-on-year

    Free Cash Flow

    Free cash flow

    $259.90M
    EW annual free cash flow is $259.90 million

    Free cash flow 1-year change

    -58.71%
    EW annual free cash flow is down -58.71% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    79.46%
    EW annual gross profit margin is 79.46%

    Operating margin

    27.21%
    EW annual operating profit margin is 27.21%

    Net margin

    76.75%
    EW annual net profit margin is 76.75%

    ROA & ROE

    ROA

    37.24%
    EW annual return on assets is 37.24%

    ROE

    49.75%
    EW annual return on equity is 49.75%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    10.69
    EW price to earnings ratio is 10.69

    PE ratio Sector rank

    14.63%
    EW price to earnings ratio is higher than 14.63% of companies in Healthcare sector

    PB Ratio

    PB ratio

    4.33
    EW price to book ratio is 4.33

    PB ratio Sector rank

    79.74%
    EW price to book ratio is higher than 79.74% of companies in Healthcare sector

    PS Ratio

    PS ratio

    7.92
    EW price to sales ratio is 7.92

    PS ratio Sector rank

    74.64%
    EW price to sales ratio is higher than 74.64% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $41.44B
    EW enterprise value is $41.44 billion

    Enterprise value Sector rank

    97.2%
    EW enterprise value is higher than 97.2% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    23.83
    EW EV/EBITDA is 23.83

    EV/EBITDA Sector rank

    93.54%
    EW EV/EBITDA is higher than 93.54% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.18
    EW annual current ratio is 4.18

    Quick ratio

    3.45
    EW annual quick ratio is 3.45

    Leverage

    Debt to equity

    0.06
    EW annual debt to equity ratio is 0.06

    Interest coverage ratio

    74.75
    EW annual interest coverage ratio is 74.75

    Risk & Stability

    Piotroski F-Score

    6
    EW piotroski f-score is 6

    Altman Z-Score

    11.44
    EW altman z-score is 11.44

    Analyst ratings

    Recent major analysts updates

    Apr 25, 25 Canaccord Genuity
    Hold
    Apr 24, 25 Piper Sandler
    Overweight
    Apr 24, 25 Baird
    Neutral
    Apr 11, 25 Truist Securities
    Hold
    Feb 13, 25 Canaccord Genuity
    Hold
    Feb 13, 25 Barclays
    Overweight
    Feb 12, 25 RBC Capital
    Outperform
    Feb 12, 25 Piper Sandler
    Neutral
    Feb 12, 25 Morgan Stanley
    Equal-Weight
    Feb 12, 25 Evercore ISI Group
    In-Line

    Institutional Ownership

    Screeners with EW included

    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Most recommended stocks
    Stocks above SMA 50
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    Stocks ready to break out
    Healthcare sector
    • What is the ticker symbol for Edwards Lifesciences?
    • Does Edwards Lifesciences pay dividends?
    • What sector is Edwards Lifesciences in?
    • What industry is Edwards Lifesciences in?
    • What country is Edwards Lifesciences based in?
    • When did Edwards Lifesciences go public?
    • Is Edwards Lifesciences in the S&P 500?
    • Is Edwards Lifesciences in the NASDAQ 100?
    • Is Edwards Lifesciences in the Dow Jones?
    • When was Edwards Lifesciences's last earnings report?
    • When does Edwards Lifesciences report earnings?
    • Should I buy Edwards Lifesciences stock now?

    What is the ticker symbol for Edwards Lifesciences?

    The ticker symbol for Edwards Lifesciences is NYSE:EW

    Does Edwards Lifesciences pay dividends?

    No, Edwards Lifesciences does not pay dividends

    What sector is Edwards Lifesciences in?

    Edwards Lifesciences is in the Healthcare sector

    What industry is Edwards Lifesciences in?

    Edwards Lifesciences is in the Medical Devices industry

    What country is Edwards Lifesciences based in?

    Edwards Lifesciences is headquartered in United States

    When did Edwards Lifesciences go public?

    Edwards Lifesciences's initial public offering (IPO) was on March 27, 2000

    Is Edwards Lifesciences in the S&P 500?

    Yes, Edwards Lifesciences is included in the S&P 500 index

    Is Edwards Lifesciences in the NASDAQ 100?

    No, Edwards Lifesciences is not included in the NASDAQ 100 index

    Is Edwards Lifesciences in the Dow Jones?

    No, Edwards Lifesciences is not included in the Dow Jones index

    When was Edwards Lifesciences's last earnings report?

    Edwards Lifesciences's most recent earnings report was on Apr 23, 2025

    When does Edwards Lifesciences report earnings?

    The next expected earnings date for Edwards Lifesciences is Jul 24, 2025

    Should I buy Edwards Lifesciences stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page